Microbot Medical INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Microbot Medical Inc. has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NASDAQ
Microbot Medical is asking shareholders to vote on several proposals at its 2025 Annual Meeting, including director elections, executive compensation, and an increase in authorized shares.
NASDAQ
Microbot Medical Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
DEF: Microbot Medical Seeks Stockholder Approval for Share Issuance and Increase in Authorized Shares
Microbot Medical is holding a special meeting to seek stockholder approval for issuing shares related to a recent offering and to increase the number of authorized shares of common stock.
NASDAQ
Microbot Medical Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
Microbot Medical Inc. has scheduled its 2024 Annual Meeting of Shareholders for December 17, 2024, to address director elections, an amendment to the company's performance award plan, and the ratification of its independent accounting firm.